A Local, Multicentre, Open-Label, Extension Trial To Evaluate The Efficacy And Safety Of Fesoterodine Flexible Dose Regimen In Elderly Patients With Overactive Bladder [EXTENSION OF 700039445].
Latest Information Update: 08 Sep 2015
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms SOFIA-extension
- 25 Jul 2013 New trial record